Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin dilutions in upper limb spasticity
NCT00465738Phase 3Completed
- Sponsor
- Merz
- Start
- Feb 2007
- Primary completion
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 8
01
Overview
A Phase 3 trial of incobotulinumtoxinA in Upper limb spasticity, sponsored by Merz. Started Feb 2007; status: completed.
02
Drugs
incobotulinumtoxinA
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT00465738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465738.